Graphite Bio Declares Special Dividend In Connection with Proposed Merger with Lenz Therapeutics
Special dividend estimated to be $1.03 per share Payment of special dividend conditioned upon closing of merger SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–$GRPH... Read more.
In Accordance with NYSE Rule 303A.08, this Press Release Makes Public the Grant of an Employment Inducement Award
LEHI, Utah–(BUSINESS WIRE)–As required by the rules of the New York Stock Exchange, Weave Communications, Inc. (NYSE: WEAV), a leading all-in-one customer... Read more.
Certain DWS Closed-End Funds Declare Monthly Distributions
NEW YORK–(BUSINESS WIRE)–The DWS closed-end funds listed below announced today their regular monthly distributions. Details are as follows: March Monthly... Read more.
Certain DWS Closed-End Funds Declare Monthly Distributions
NEW YORK–(BUSINESS WIRE)–The DWS closed-end funds listed below announced today their regular monthly distributions. Details are as follows: March Monthly... Read more.
Castle Biosciences to Present New Data Highlighting the Clinical Value of its Dermatologic Tests for Patients with Skin Cancer at the 2024 American Academy of Dermatology (AAD) Annual Meeting
Castle’s presentations at AAD include the latest findings from the Company’s ongoing collaboration with the National Cancer Institute’s Surveillance, Epidemiology,... Read more.
AM Best Places Credit Ratings of The Pie Insurance Company and Pie Casualty Insurance Company Under Review With Negative Implications
OLDWICK, N.J.–(BUSINESS WIRE)–#insurance—AM Best has placed under review with negative implications the Financial Strength Rating of A- (Excellent)... Read more.
Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing breakthrough treatments... Read more.
Olo and Qu Announce Revolutionary Partnership: Enabling Data-Driven Hospitality for Restaurants
Announced live at Olo’s annual customer conference, Beyond4, Olo’s Pay and Engage suites will integrate seamlessly into Qu’s POS effective later this year... Read more.
Janux Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
Recently presented positive Phase 1 clinical trial data for PSMA-TRACTr JANX007 in mCRPC and for EGFR-TRACTr JANX008 in solid tumors Enrollment ongoing for JANX007... Read more.
EPIC Insurance Brokers & Consultants’ 2024 Power Broker Winners Recognized for Excellence
Risk & Insurance awarded three EPIC team members for their commitment to client service, industry expertise, and innovative risk management strategies SAN FRANCISCO–(BUSINESS... Read more.